Mindfulness
BehavioralRefer to the arm description
NCT Number: NCT07496138
The goal of this single-arm pilot clinical trial is to evaluate whether a group-based mindfulness intervention can improve mental health and sleep among parents who are informal caregivers of children with autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD). The main questions it aims to answer are:
Does participating in an 8-week mindfulness program reduce symptoms of stress, anxiety, depression, and insomnia in caregivers? Does participating in an 8-week mindfulness program improve mindfulness in caregivers? What are the caregivers' experiences in participating in the 8-week mindfulness program?
Participants will:
* Attend weekly group-based mindfulness sessions for 1.5 hours over eight weeks. * Complete assessments before starting the program (baseline) and immediately after the final session. * Participate in a qualitative feedback interview after the final session.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Refer to the arm description
Time frame: Baseline, end of treatment at 8 weeks
Stress was measured using the 14-item Perceived Stress Scale (PSS). Possible scores range from 0 to 56, with higher scores indicating a higher stress level.
Time frame: Baseline, end of treatment at 8 weeks
Depressive symptoms were measured using the 9-item Patient Health Questionnaire (PHQ-9). Possible scores range from 0 to 27, with higher scores indicating higher depression severity.
Time frame: Baseline, end of treatment at 8 weeks
Axniety symptoms were measured using the Generalized Anxiety Disorder 7-item (GAD-7). Possible scores range from 0 to 21, with higher scores indicating higher anxiety severity.
Time frame: Baseline, end of treatment at 8 weeks
Insomnia symptoms were measured using the Insomnia Severity Index (ISI). It consists of 7 items. Possible scores range from 0 to 28, with higher scores indicating higher insomnia severity.
Time frame: Baseline, end of treatment at 8 weeks
Mindfulness ability was measured using the 15-item Five-Facet Mindfulness Questionnaire (FFMQ-15). Possible scores range from 15 to 75, with higher scores indicating a higher mindfulness level.
Time frame: End of treatment at 8 weeks
Attendance, practice, and overall impression were measured using a 9-question survey, with 3 questions on attendance, 2 on overall impression, and 4 on practice. In particular, there are 2 rating-scale items in the overall impression construct and 1 in the practice construct for the probability of future use of mindfulness practice. The scales range from 0 to 10, where higher scores indicate a better overall impression/greater probability for continued use of the practice.
Time frame: End of treatment at 8 weeks
Unpleasant experiences and harm were assessed using a 10-question survey: 3 on unpleasant experiences, 2 on harm, and 5 on coping. In particular, one Likert scale was used to assess the perceived helpfulness item in the coping construct. The scale ranges from 1 to 5, where a higher score indicates greater helpfulness of the support.
Contact information is provided by the study sponsor or research team.
The University of Hong Kong
Other
Effects of a Mindfulness-based Intervention on Stress, Mental Health, and Sleep Among Informal Caregivers of Children With Special Educational Needs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06644573
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Aventura, Florida, United States
View Trial DetailsNCT07711769
Behavior, Dyssomnias
Hong Kong
View Trial DetailsNCT07666633
Behavior, Behavioral Symptoms
Kaohsiung City, Taiwan
View Trial DetailsNCT07043530
Behavior, Dyssomnias
Mérida, Mexico
View Trial Details